Restenosis trial to begin in October:
This article was originally published in Clinica
Executive Summary
Spectranetics has said it hopes to begin its in-stent restenosis clinical trial in October and has appointed Duke Clinical Research Institute as the trial co-ordination centre. The trial will assess Spectranetics' CVX-300 excimer laser coronary angioplasty system with angioplasty versus angioplasty alone on patients with blocked stents (see Clinica No 842, p 17).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.